Dr Ling Yang
- Clinical Trial Service Unit
Ling Yang qualified in Medicine at South-Eastern University, China, in 1995, then gained her MSc in Bio-statistics in 1998 at the same university, and her PhD in Epidemiology at the University of Tampere in Finland in 2005. Before moving to the University of Oxford in 2007, she worked at the Chinese Academy of Medical Science (CAMS) and Ministry of Health in Beijing (China), WHO International Agency for Research on Cancer in Lyon (IARC/WHO, France) and Karolinska Institute in Stockholm (Sweden). She is a Senior Epidemiologist at CTSU, University of Oxford, and also leads the Long-term Follow-up Working Group for the China Kadoorie Biobank study. Her main research focuses on women’s reproductive health, environmental causes of chronic diseases, especially cancer, based on big cohort studies, and evidence-based medicine using national survey data to provide strategies for chronic disease prevention and control in developing countries.
Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women: a 9-year prospective study of 0·5 million people.
Liu X. et al, (2018), Lancet Public Health
Association between major depressive episode and risk of type 2 diabetes: A large prospective cohort study in Chinese adults.
Meng R. et al, (2018), J Affect Disord, 234, 59 - 66
Age at Menarche and Incidence of Diabetes: A Prospective Study of 300,000 Women in China.
Yang L. et al, (2018), Am J Epidemiol, 187, 190 - 198
Excess risk of major vascular diseases associated with airflow obstruction: a 9-year prospective study of 0.5 million Chinese adults.
Kurmi OP. et al, (2018), Int J Chron Obstruct Pulmon Dis, 13, 855 - 865
Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.
Millwood IY. et al, (2018), JAMA Cardiol, 3, 34 - 43